Regulatory Reform Panel Urges Better Trial Environment, SaMD Review

December 24, 2021
The government’s Regulatory Reform Promotion Council on December 22 compiled a paper listing near-term regulatory reform initiatives and proposals, calling for deregulations to facilitate clinical trials and revise the review process for software as a medical device (SaMD). In the...read more